# Meritage Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/meritage-pharma

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Website: www.meritagepharma.com
- Total disclosed funding: $23M
- Latest round: Series A (Jun 16, 2008)
- Investors on record: 3

## About

Meritage Pharma, Inc. is a pharmaceutical company focused on developing innovative health solutions to address various medical conditions while ensuring patient safety and efficacy in its products.Meritage Pharma, Inc. was founded in 2008 and is headquartered in San Diego, US. The company specializes in the development of pharmaceutical products targeting unmet medical needs. In February 2015, Meritage Pharma was acquired by Shire PLC for an upfront fee of USD 70.00 mn, with additional contingent payments based on development and regulatory milestones. Since its inception, the firm has engaged in five different deals, with the latest being the acquisition by Shire PLC. The founder's prior experience is not documented in the available information.Meritage Pharma, Inc. primarily operates within the pharmaceutical sector, specializing in innovative health solutions. The company's core offerings include a range of pharmaceutical products that address various medical conditions, focusing on efficacy and safety for end users. These products cater to healthcare providers, patients, and healthcare institutions, emphasizing improved patient outcomes and accessibility to essential medications. The company's target customer base spans multiple geographical regions, including North America, Europe, and parts of Asia, demonstrating its commitment to quality and patient care.The revenue model for Meritage Pharma, Inc. is based on direct sales and potential partnerships with healthcare providers and distributors. Transactions occur through direct-to-consumer sales and B2B arrangements, facilitating access to their pharmaceutical products. The company implements various pricing structures, including tiered pricing for different product lines, which align with industry standards. Revenue may also be bolstered through subscription models for certain specialty medications, where consistent patient care is crucial.Meritage Pharma, Inc. is focused on further product development and market expansion. The company is actively working on upcoming new products, with specific release dates yet to be disclosed. Plans for geographic expansion include targeting additional markets within Europe and Asia by 2025. The recent acquisition by Shire PLC for USD 70.00 mn will support these initiatives, with a portion of the funding allocated towards achieving development and regulatory milestones.

## Funding rounds

- Series A, Jun 16, 2008, $23M — Domain Associates, Latterell Venture Partners, Vertical Group

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A
- Latterell Venture Partners (https://capitalatlas.ai/funds/latterell-venture-partners) — Series A
- Vertical Group (https://capitalatlas.ai/funds/vertical-group) — Series A